39 results
8-K
EX-10.1
ALNY
Alnylam Pharmaceuticals Inc
3 Aug 23
Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity
8:10am
and early development, investor and KOL engagement, scientific presentations and support to commercial and medical teams, and such other duties
PRE 14A
miebv7lcctw4 rlhp50k
11 Mar 19
Preliminary proxy
5:07pm
PRER14A
5mhtt5w8
18 Mar 19
Preliminary revised proxy
5:24pm
8-K
EX-99.1
rx2nco828a06r xb
15 Feb 24
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
pyxm 1oedv1is6b
6 Aug 20
Results of Operations and Financial Condition
8:10am
DEF 14A
3xvi79 f7ag9g4fumlb
28 Apr 05
Definitive proxy
12:00am
S-1
EX-3.1
vtvqoqa1
27 Feb 04
IPO registration
12:00am